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A 58-year-old-man underwent an esophagogastroduodenoscopy (EGD) for the
evaluation of dyspepsia on February 28,
2020. Thickened folds were described in the
distal esophagus. Biopsies revealed intestinal metaplasia with low-grade dysplasia (LGD) that was conﬁrmed by our
pathology department. The patient was
referred to our center for further endoscopic evaluation. After discussion with the
patient, the decision was made to repeat the

endoscopy after intensive antacid medication. The patient was scheduled for end of
March. Because of the COVID-19 pandemic, the patient’s procedure was
rescheduled twice because (i) the pandemic
at the time in New York was severe and
endoscopy resources for management of
nonemergent patients was low and (ii)
guidelines have recommended that endoscopic management of Barrett’s with LGD
is low priority to semiurgent depending on
the guideline (1,2). It should be noted that
the American College of Gastroenterology
guidelines recommended not to delay
evaluation of premalignant conditions (3).
However, Barrett’s with LGD is not speciﬁcally mentioned unlike the aforementioned guidelines.
The patient eventually underwent EGD
13 weeks after the initial procedure, after
much convincing because he was fearful to
come to the hospital; because of ongoing
COVID-19 infections being admitted to the
hospital. A short segment of Barrett’s was
seen in the distal esophagus (Prague class
C0M2). No raised lesions were seen, however, on narrow band imaging; a disrupted
pit pattern was seen with a shallow ulcer
consistent with neoplasia (Figure 1a) (4).
The decision was made to perform band ligation endoscopic mucosal resection of the
abnormal area. The histology was consistent
with focal Barrett’s intramucosal cancer in
the background of high-grade dysplasia
(Figure 1c) that was conﬁrmed by 2 gastrointestinal pathologists experienced in
Barrett’s pathology in a high-volume Barrett’s referral center. Surrounding biopsies
and brushings were negative for dysplasia.

This patient’s EGD was delayed 3
months because of the COVID-19 pandemic. Fortunately, the endoscopic mucosal resection was curative and the
possible consequence from the delay was
minimized. This case provides a few lessons for the management of Barrett’s
during the COVID-19 pandemic. First,
every eﬀort should be made not to delay
evaluation of Barrett’s with dysplasia. In
this case, the degree of dysplasia was not
appreciated on the ﬁrst examination because of under sampling vs the full extent
of the lesion not being appreciated. There
was likely at least high-grade dysplasia
present that was not appreciated on
random biopsies. In cases of suspected
dysplasia, adjunctive use of narrow band
imaging may aid in detection and sampling. In addition, allowing suﬃcient
time for proper inspection may also increase the yield of dysplasia detection (5).
Second, cases of Barrett’s with dysplasia
that were delayed because of a stressed
endoscopy resource should be scheduled
as a priority, when endoscopy resumes
after a pandemic. Third, patients should
be educated not to self-delay evaluation
of Barrett’s with dysplasia; which almost
occurred in this case. Fourth, as we are
seeing in practice, even non-COVID-19
patients are aﬀected by the pandemic. It
has been estimated that delays to cancer
diagnosis could lead to an additional
30,000 deaths in the United States (6). It is
important that health systems triage
delayed cases appropriately. Our large
health system (with over 11,000 hospitalized COVID-19 patients treated)

Figure 1. A delayed diagnosis of Barrett's cancer. (a) Narrow band imaging showing a disrupted pit pattern within a Barrett’s segment (yellow arrow), (b)
abnormal area postendoscopic resection (yellow arrow) and (c) histology showing a small foci of intramucosal adenocarcinoma with microscopic clusters of
neoplastic cells infiltrating the lamina propria; arrows. Background of Barrett’s metaplasia/intestinal metaplasia; asterix (H&E stain 3200).
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identiﬁed all cases of potential gastrointestinal neoplasia diagnosis that were
delayed and prioritized them when endoscopy services resumed.
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